Puma Biotechnology Inc. | Ownership
Companies that own Puma Biotechnology Inc.
Henderson Global Investors Ltd.
3,302,021
8.68%
-1,180,285
0.06%
06/30/2018
OrbiMed Advisors LLC
2,732,881
7.19%
91,220
1.25%
06/30/2018
The Vanguard Group, Inc.
2,672,656
7.03%
80,289
0%
06/30/2018
BlackRock Fund Advisors
2,274,873
5.98%
97,022
0.01%
06/30/2018
Consonance Capital Management LP
2,089,117
5.49%
2,089,117
4.91%
06/30/2018
SSgA Funds Management, Inc.
1,971,243
5.18%
481,475
0.01%
06/30/2018
Partner Fund Management LP
1,620,477
4.26%
-439,296
1.23%
06/30/2018
venBio Select Advisor LLC
1,034,375
2.72%
209,007
1.55%
06/30/2018
Fidelity Management & Research Co.
1,014,210
2.67%
-47,800
0.01%
06/30/2018
Jennison Associates LLC
950,998
2.5%
465,453
0.04%
06/30/2018
| Address |
10880 Wilshire Boulevard
Los Angeles California 90024
United States
|
|
Employees
|
- |
| Website |
http://www.pumabiotechnology.com |
| Updated |
07/08/2019 |
| Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. |
